We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORBK
3026
DELISTED
Orbotech Ltd
ORBK
$6K ﹤0.01%
98
-1,914
-95% -$115K
FSNN
3027
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$6K ﹤0.01%
4,525
+3,906
+631% +$6.96K
MACK
3028
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$6K ﹤0.01%
1,071
-23,158
-96% -$106K
VIIX
3029
DELISTED
VelocityShares VIX Short Term ETN
VIIX
$6K ﹤0.01%
101
+74
+274% +$5.39K
PFSW
3030
DELISTED
PFSweb, Inc.
PFSW
$6K ﹤0.01%
1,152
-7,323
-86% -$43.8K
CEMI
3031
DELISTED
Chembio diagnostics, Inc.
CEMI
$6K ﹤0.01%
1,200
-2,521
-68% -$16.4K
LAC
3032
DELISTED
Lithium Americas Corp. Common Shares
LAC
$6K ﹤0.01%
1,627
+607
+60% +$2.16K
ACTG icon
3033
Acacia Research
ACTG
$471M
$5K ﹤0.01%
+1,500
New +$4.66K
AGIO icon
3034
Agios Pharmaceuticals
AGIO
$1.94B
$5K ﹤0.01%
69
+53
+331% +$3.09K
ANGI icon
3035
Angi Inc
ANGI
$186M
$5K ﹤0.01%
32
-896
-97% -$145K
ANIX icon
3036
Anixa Biosciences
ANIX
$112M
$5K ﹤0.01%
999
-373
-27% -$1.78K
ARVN icon
3037
Arvinas
ARVN
$585M
$5K ﹤0.01%
311
-572
-65% -$10.1K
BBU
3038
DELISTED
Brookfield Business Partners
BBU
$5K ﹤0.01%
213
-11,542
-98% -$258K
BBVA icon
3039
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
$5K ﹤0.01%
824
-676
-45% -$3.98K
BCC icon
3040
Boise Cascade
BCC
$2.97B
$5K ﹤0.01%
+200
New +$5.39K
BOOM icon
3041
DMC Global
BOOM
$155M
$5K ﹤0.01%
93
-620
-87% -$25.1K
BSV icon
3042
Vanguard Short-Term Bond ETF
BSV
$45.6B
$5K ﹤0.01%
64
CARG icon
3043
CarGurus
CARG
$3.32B
$5K ﹤0.01%
113
+54
+92% +$2.11K
CATH icon
3044
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
$5K ﹤0.01%
+131
New +$4.36K
CBU icon
3045
Community Bank
CBU
$3.37B
$5K ﹤0.01%
+81
New +$5K
CLPR
3046
Clipper Realty
CLPR
$46.5M
$5K ﹤0.01%
352
-1,016
-74% -$13.3K
CMCO icon
3047
Columbus McKinnon
CMCO
$555M
$5K ﹤0.01%
145
+11
+8% +$383
DOG
3048
ProShares Short Dow30
DOG
$87M
$5K ﹤0.01%
86
-96
-53% -$5.46K
EXAS
3049
DELISTED
Exact Sciences
EXAS
$5K ﹤0.01%
55
+23
+72% +$1.96K
FLNT
3050
Fluent
FLNT
$125M
$5K ﹤0.01%
159
-2,870
-95% -$84.6K

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.